Brent Saunders to return as Bausch + Lomb CEO — Amylyx counters Wall Street noise, cites demand for ALS drug—New VC Curie.bio makes its debut with $500m+ war chest-- See more on our front page news http://bit.ly/w28kSd #bauschandlomb #ceo #brentsaunders #als #funding #venturecapital #biotech #biotechnology #biopharmaceuticals #pharma #pharmanews #cafepharma
#bauschandlomb #ceo #brentsaunders #ALS #funding #VentureCapital #biotech #biotechnology #biopharmaceuticals #pharma #pharmanews #cafepharma